Lotus
Accelerating Medical Breakthroughs Through AI-Powered Clinical Trials
Introduction
Lotus is an AI-powered end-to-end platform transforming clinical trials by automating patient recruitment, streamlining workflows, and enhancing engagement. Our comprehensive solution combines intelligent screening technology with personalized patient support to help clinical researchers bring life-saving treatments to market faster. We're bridging the gap between technological innovation and practical clinical implementation to revolutionize how medical discoveries reach patients
Problem
Clinical trials face critical bottlenecks that delay medical innovations from reaching patients. The recruitment process remains expensive, time-consuming, and often inaccurate, with most sites still relying on manual outreach and follow-up. Once enrolled, high dropout rates (~30%) and missed data points lead to trial failures, with each patient dropout costing $19,533 on average. Despite numerous technological advances, pharmaceutical leaders report a persistent gap. There is still no comprehensive, fully automated solution designed for real-world clinical settings that effectively addresses both patient enrollment and retention challenges seamlessly and practically.
Opportunity
Lotus has developed an innovative end-to-end platform designed to revolutionize clinical trials by addressing the critical challenges of patient recruitment and engagement. Based on extensive market research and stakeholder interviews, our solution offers a comprehensive approach that distinguishes it from competitors in the market.
Lotus offers a one-stop shop platform with three integrated components:
a) AI-powered screening that automates patient eligibility identification
b) Workflow automation to streamline administrative processes
c) Patient-centric engagement tools, including a 24/7 hotline, patient-friendly app, and multilingual support
Through this integrated approach, Lotus aims to accelerate groundbreaking medical discoveries by making clinical trials more efficient, patient-friendly, and ultimately more successful in bringing new treatments to market.